Effect of a high protein diet in patients with the nephrotic syndrome. 1989

H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
Department of Nephrology, Freeman Hospital, University of Newcastle upon Tyne, U.K.

1. Twelve patients with the nephrotic syndrome were prescribed for 4 week periods a normal protein diet (NPD) containing 1 g of protein/kg ideal body weight. They were then prescribed for further 4 week periods in random order diets with high (HPD) and low (LPD) protein contents, respectively 2.0 and 0.5 g/kg ideal body weight. 2. Compliance was confirmed by dietary history and measurement of urinary excretion. 3. Serum albumin was the same on all diets. Twenty-four hour urinary protein excretion increased progressively with increasing dietary protein (LPD 6.1 g. NPD 8.2 g. HPD 9.2 g). Recumbent plasma renin activity and serum phosphate were significantly increased on HPD (plasma renin activity: LPD 5.7, NPD 4.6, HPD 8.2 pmol of angiotensin I min-1 1(-1); serum phosphate: LPD 1.27, NPD 1.26, HPD 1.41 mmol/l). 4. There was no evidence of protein-induced hyperfiltration or hyperperfusion: 51Cr-ethylenediaminetetra-acetate and [125I]iodohippurate clearances were similar on all three diets. 5. Since proteinuria, increased plasma renin levels and hyperphosphataemia may contribute to progression of renal failure and because HPD did not improve hypoalbuminaemia, the use of HPD in the nephrotic syndrome should be abandoned. 6. Until it can be established that LPD, which is accompanied by the least proteinuria, does not, with long-term feeding, lead to malnutrition, NPD should be used in the treatment of the nephrotic syndrome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004044 Dietary Proteins Proteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS. Proteins, Dietary,Dietary Protein,Protein, Dietary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
November 1989, Kidney international. Supplement,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
January 2012, Kidney & blood pressure research,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
February 1955, The Medical journal of Australia,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
August 1956, Lancet (London, England),
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
September 1980, Klinicheskaia meditsina,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
November 1989, Kidney international. Supplement,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
December 1976, JPMA. The Journal of the Pakistan Medical Association,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
January 1980, Terapevticheskii arkhiv,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
December 1951, Nederlands tijdschrift voor geneeskunde,
H Mansy, and T H Goodship, and J S Tapson, and G H Hartley, and P Keavey, and R Wilkinson
December 1964, The Journal of clinical investigation,
Copied contents to your clipboard!